CIK 0001055726 · Non-accelerated filer<br>Smaller reporting company
INOVIO PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- INO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330969592
- Phone
- 8584103134
- Business address
- 660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING, PA, 19462
- Former names
- INOVIO BIOMEDICAL CORP, GENETRONICS BIOMEDICAL CORP, GENETRONICS BIOMEDICAL LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-20 | Sumner Michael John Chief Medical Officer | Option exercise | +9,450 | 44,731 | ||
| 2026-05-20 | Sumner Michael John Chief Medical Officer | Shares withheld for taxes | −2,693 | $1.23 | $3K | 42,038 |
| 2026-05-20 | Sumner Michael John Chief Medical Officer | Option exercise · Restricted Stock Unit | −9,450 | 18,900 | ||
| 2026-05-20 | Sumner Michael John Chief Medical Officer | Grant or award · Common Stock Option | +46,876 | 46,876 | ||
| 2026-05-20 | Sumner Michael John Chief Medical Officer | Grant or award · Restricted Stock Unit | +37,684 | 37,684 | ||
| 2026-05-20 | Shea Jacqueline Elizabeth Chief Executive Officer | Option exercise | +28,296 | 123,327 | ||
| 2026-05-20 | Shea Jacqueline Elizabeth Chief Executive Officer | Shares withheld for taxes | −12,306 | $1.23 | $15K | 111,021 |
| 2026-05-20 | Shea Jacqueline Elizabeth Chief Executive Officer | Option exercise · Restricted Stock Unit | −28,296 | 56,592 | ||
| 2026-05-20 | Shea Jacqueline Elizabeth Chief Executive Officer | Grant or award · Common Stock Option | +123,760 | 123,760 | ||
| 2026-05-20 | Shea Jacqueline Elizabeth Chief Executive Officer | Grant or award · Restricted Stock Unit | +100,240 | 100,240 | ||
| 2026-05-20 | Miller Ann Calby Director | Grant or award · Common Stock Options | +41,800 | 41,800 | ||
| 2026-05-20 | Miller Ann Calby Director | Grant or award · Restricted Stock Unit | +34,200 | 34,200 | ||
| 2026-05-20 | Humeau Laurent Chief Scientific Officer | Option exercise | +6,027 | 48,986 | ||
| 2026-05-20 | Humeau Laurent Chief Scientific Officer | Shares withheld for taxes | −2,163 | $1.23 | $3K | 46,823 |
| 2026-05-20 | Humeau Laurent Chief Scientific Officer | Option exercise · Restricted Stock Unit | −6,027 | 12,054 | ||
| 2026-05-20 | Humeau Laurent Chief Scientific Officer | Grant or award · Common Stock Option | +34,160 | 34,160 | ||
| 2026-05-20 | Humeau Laurent Chief Scientific Officer | Grant or award · Restricted Stock Unit | +27,440 | 27,440 | ||
| 2026-05-20 | DANSEY ROGER D Director | Grant or award · Common Stock Options | +41,800 | 41,800 | ||
| 2026-05-20 | DANSEY ROGER D Director | Grant or award · Restricted Stock Unit | +34,200 | 34,200 | ||
| 2026-05-20 | Weiner David B. Director | Grant or award · Common Stock Options | +41,800 | 41,800 |
Page 1 of 17 · 322 trades